To study the effect of SOT in patients with pulmonary vascular diseases (PVD) defined as pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension (PH) who permanently live \>2500m on pulmonary artery pressure (PAP) and other hemodynamics by echocardiography and in relation to blood gases at 2840m with and without SOT.
Patients with PVD diagnosed with precapillary PH with right heart catheterization and classified to groups 1 and 4 (PAH or CTEPH) who permanently live at HA \>2500 (PVDHA) will have echocardiografy to assess PAP, cardiac output and other hemodynamics and arterial blood gas to assess SaO2, PaO2 and PaCO2 near their living altitude in Quito at 2840m whilst breathing ambient air or SOT at 10l/min flow via a face mask with reservoir.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
24
Mobile oxygen via pressurized bottle or mobile oxygen concentrator will be applied
Patients will reveice pressurized air via a nasal cannula
University Hospital Zürich
Zurich, Switzerland
Change in Pulmonary Artery Pressure with SOT vs. placebo
Change in PAP in mmHg assessed by echocardiography with SOT compared to ambient air (placebo) 10l/min via facial mask
Time frame: at 15 min of breathing ambient air or supplemental oxygen
Change in Cardiac Output with SOT vs. placebo
Change in cardiac output (l/min) assessed by echocardiography with SOT compared to ambient air (placebo) 10l/min via facial mask
Time frame: at 15 min of breathing ambient air or supplemental oxygen
Change in right to left heart diameter ratio with SOT vs. placebo
Change in right to left heart diameter ratio assessed by echocardiography with SOT compared to ambient air (placebo) 10l/min via facial mask
Time frame: at 15 min of breathing ambient air or supplemental oxygen
Change in tricuspid annular plane systolic excursion (TAPSE) with SOT vs. placebo
Change in tricuspid annular plane systolic excursion (TAPSE) with SOT compared to ambient air (placebo) 10l/min via facial mask
Time frame: at 15 min of breathing ambient air or supplemental oxygen
Change in right atrial area with SOT vs. placebo
Change in right atrial area by echocardiography with SOT compared to ambient air (placebo) 10l/min via facial mask
Time frame: at 15 min of breathing ambient air or supplemental oxygen
Change in right heart strain with SOT vs. placebo
Change in in right heart strain by echocardiography with SOT compared to ambient air (placebo) 10l/min via facial mask
Time frame: at 15 min of breathing ambient air or supplemental oxygen
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Change in ph by arterial blood gases with SOT vs. placebo
Changes in ph by arterial blood gases SaO2, PaO2, PaCO2 with SOT compared to ambient air (placebo) 10l/min via facial mask
Time frame: at 15 min of breathing ambient air or supplemental oxygen
Change in PaO2 by arterial blood gases with SOT vs. placebo
Changes in PaO2 by arterial blood gases with SOT compared to ambient air (placebo) 10l/min via facial mask
Time frame: at 15 min of breathing ambient air or supplemental oxygen
Change in PaCO2 by arterial blood gases with SOT vs. placebo
Changes in PaCO2 by arterial blood gases with SOT compared to ambient air (placebo) 10l/min via facial mask
Time frame: at 15 min of breathing ambient air or supplemental oxygen